연구성과로 돌아가기
JCR 2023 저널 목록 (407 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| European Journal of Pharmacology | ELSEVIER | 0014-2999 | 1879-0712 | SCIE | PHARMACOLOGY & PHARMACY | 37,168 | 4.2 | Q1 | 21.0 | 79.0 | 75/354 | 4.3 | Q1 | 4.1 | 0.8 | 1.32 | 40/354 | Q1 | 88.84 | 0.022 | 4.750 | 0.796 | Q2 | 597 | 97.8% | 8.6 | 6.5 | 584 | 10.9% | 2025-03-24 17:36:10 | 바로가기 |
| Expert Review of Anti-Infective Therapy | TAYLOR & FRANCIS LTD | 1478-7210 | 1744-8336 | SCIE | PHARMACOLOGY & PHARMACY | 6,152 | 4.2 | Q1 | 21.0 | 79.0 | 75/354 | 5.7 | Q1 | 4.1 | 1.3 | 0.74 | 149/354 | Q2 | 58.05 | 0.006 | 1.221 | 1.342 | Q1 | 98 | 42.9% | 6.3 | 5.2 | 42 | 10.2% | 2025-03-24 17:36:21 | 바로가기 |
| Journal of the Korean Ceramic Society | SPRINGER HEIDELBERG | 1229-7801 | 2234-0491 | SCIE | MATERIALS SCIENCE, CERAMICS | 1,490 | 2.7 | Q1 | 21.0 | 79.0 | 7/31 | 2.4 | Q2 | 2.0 | 0.9 | 0.53 | 8/31 | Q2 | 75.81 | 0.001 | 0.244 | 0.325 | Q2 | 72 | 88.9% | 3.8 | 6.4 | 64 | 2.9% | 2025-03-24 17:25:44 | 바로가기 |
| Materials Today Chemistry | ELSEVIER SCI LTD | 2468-5194 | 2468-5194 | SCIE | CHEMISTRY, MULTIDISCIPLINARY | 9,990 | 6.7 | Q1 | 21.0 | 79.0 | 49/231 | 7.1 | Q1 | 6.5 | 1.7 | 1.21 | 43/231 | Q1 | 81.60 | 0.011 | 2.376 | 1.053 | Q2 | 533 | 96.2% | 2.1 | 5.0 | 513 | 7.6% | 2025-03-24 16:59:28 | 바로가기 |
| PHYSICAL REVIEW D | AMER PHYSICAL SOC | 2470-0010 | 2470-0029 | SCIE | PHYSICS, PARTICLES & FIELDS | 227,613 | 4.6 | Q1 | 21.0 | 79.0 | 7/31 | 4.3 | Q1 | 3.1 | 1.6 | 1.18 | 9/31 | Q2 | 72.58 | 0.167 | 36.716 | 1.057 | Q2 | 3543 | 99.7% | 8.6 | 8.9 | 3531 | 57.8% | 2025-03-24 17:55:10 | 바로가기 |
| RADIOTHERAPY AND ONCOLOGY | ELSEVIER IRELAND LTD | 0167-8140 | 1879-0887 | SCIE | ONCOLOGY | 21,943 | 4.9 | Q1 | 21.0 | 79.0 | 68/322 | 5.4 | Q1 | 4.4 | 1.1 | 1.41 | 46/322 | Q1 | 85.87 | 0.023 | 5.019 | 1.516 | Q1 | 360 | 91.7% | 6.6 | 6.2 | 330 | 28.0% | 2025-03-24 17:33:38 | 바로가기 |
| SAFETY SCIENCE | ELSEVIER | 0925-7535 | 1879-1042 | SCIE | ENGINEERING, INDUSTRIAL | 20,058 | 4.7 | Q1 | 21.0 | 79.0 | 15/69 | 5.3 | Q1 | 4.2 | 0.8 | 1.00 | 15/69 | Q1 | 78.99 | 0.017 | 3.657 | 0.980 | Q1 | 267 | 88.8% | 5.4 | 7.3 | 237 | 25.2% | 2025-03-24 17:11:26 | 바로가기 |
| Stem Cells Translational Medicine | OXFORD UNIV PRESS | 2157-6564 | 2157-6580 | SCIE | CELL & TISSUE ENGINEERING | 7,785 | 5.4 | Q1 | 21.0 | 79.0 | 7/31 | 6.1 | Q1 | 5.3 | 0.8 | 1.24 | 7/31 | Q1 | 79.03 | 0.007 | 1.472 | 1.381 | Q1 | 88 | 69.3% | 6.2 | 7.3 | 61 | 92.4% | 2025-03-24 16:58:24 | 바로가기 |
| Transplantation and Cellular Therapy | ELSEVIER SCIENCE INC | 2666-6375 | 2666-6367 | SCIE | TRANSPLANTATION | 2,652 | 3.6 | Q1 | 21.0 | 79.0 | 7/31 | 3.6 | Q2 | 3.2 | 1.4 | 0.92 | 8/31 | Q2 | 75.81 | 0.007 | 1.554 | 1.392 | Q1 | 295 | 94.6% | 1.9 | 6.5 | 279 | 84.5% | 2025-03-24 18:14:15 | 바로가기 |
| Transplantation Reviews | ELSEVIER SCIENCE INC | 0955-470X | N/A | SCIE | TRANSPLANTATION | 1,166 | 3.6 | Q1 | 21.0 | 79.0 | 7/31 | 3.4 | Q2 | 3.5 | 0.1 | 0.70 | 15/31 | Q2 | 53.23 | 0.002 | 0.331 | 1.083 | Q2 | 39 | 2.6% | 6.1 | 6.9 | 1 | 25.0% | 2025-03-24 18:14:16 | 바로가기 |
| BONE MARROW TRANSPLANTATION | SPRINGERNATURE | 0268-3369 | 1476-5365 | SCIE | HEMATOLOGY | 14,815 | 4.5 | Q1 | 21.1 | 78.9 | 21/97 | 4.5 | Q1 | 4.2 | 0.9 | 0.90 | 25/97 | Q2 | 74.74 | 0.013 | 2.797 | 1.456 | Q1 | 128 | 92.2% | 10.0 | 6.5 | 118 | 23.5% | 2025-03-24 17:17:35 | 바로가기 |
| Bulletin of Engineering Geology and the Environment | SPRINGER HEIDELBERG | 1435-9529 | 1435-9537 | SCIE | GEOSCIENCES, MULTIDISCIPLINARY | 12,081 | 3.7 | Q1 | 21.1 | 78.9 | 54/254 | 4.2 | Q1 | 3.4 | 1.0 | 0.86 | 74/254 | Q2 | 71.06 | 0.014 | 2.981 | 0.833 | Q2 | 454 | 96.7% | 3.9 | 7.9 | 439 | 5.0% | 2025-03-24 17:16:17 | 바로가기 |
| Developmental Cognitive Neuroscience | ELSEVIER SCI LTD | 1878-9293 | 1878-9307 | SCIE | NEUROSCIENCES | 6,014 | 4.6 | Q1 | 21.1 | 78.9 | 66/310 | 6.2 | Q1 | 4.0 | 0.7 | 1.42 | 40/310 | Q1 | 87.26 | 0.013 | 2.864 | 2.590 | Q1 | 115 | 96.5% | 5.4 | 9.1 | 111 | 96.9% | 2025-03-24 17:32:12 | 바로가기 |
| EXPERIMENTAL NEUROLOGY | ACADEMIC PRESS INC ELSEVIER SCIENCE | 0014-4886 | 1090-2430 | SCIE | NEUROSCIENCES | 20,152 | 4.6 | Q1 | 21.1 | 78.9 | 66/310 | 4.8 | Q2 | 4.4 | 0.7 | 1.17 | 73/310 | Q1 | 76.61 | 0.013 | 2.775 | 1.238 | Q2 | 228 | 91.2% | 10.3 | 7.2 | 208 | 17.2% | 2025-03-24 17:32:03 | 바로가기 |
| Hernia | SPRINGER | 1265-4906 | 1248-9204 | SCIE | SURGERY | 5,181 | 2.6 | Q1 | 21.1 | 78.9 | 62/292 | 3.1 | Q1 | 1.9 | 0.5 | 0.98 | 70/292 | Q1 | 76.20 | 0.004 | 0.965 | 0.685 | Q2 | 147 | 81.0% | 6.6 | 7.1 | 119 | 23.2% | 2025-03-24 18:13:00 | 바로가기 |
페이지 이동: